Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/17/2024 | Speculative Buy | Canaccord Genuity | ||
4/5/2024 | $2.25 → $2.75 | Neutral | Alliance Global Partners | |
3/20/2024 | Outperform → Perform | Oppenheimer | ||
2/9/2024 | Hold → Buy | Canaccord Genuity | ||
5/10/2023 | $4.25 → $4.75 | Hold → Buy | Craig Hallum | |
4/4/2023 | Underperform → Mkt Perform | Bernstein | ||
11/8/2022 | $5.00 → $2.00 | Buy → Hold | Truist | |
11/2/2022 | $3.90 | Mkt Perform | Bernstein |
IGC Pharma, Inc. ("IGC" or the "Company") (NYSE:IGC) announces that during its Annual Meeting of Stockholders scheduled for and convened on August 23, 2023 (the "Annual Meeting"), all proposals as disclosed on the Definitive Proxy Statement on Schedule 14A filed with the SEC on July 8, 2024, were passed by the requisite vote of the stockholders. Only stockholders of record on the record date of June 28, 2024, were entitled to and requested to vote at the Annual Meeting. At the Annual Meeting, all of the following proposals were approved by the requisite vote of the stockholders: (i) the election of Mr. Richard Prins and Mr. Terry Lierman to the Company's board of directors to serve as Cla
Canopy Growth's AGM to be held in a virtual-only format on Tuesday, September 24, 2024 at 1:00 PM ET.Voting is important and easy; shareholders are encouraged to vote now.Canopy Growth shareholders with a 16-digit control number can vote online at http://proxyvote.com, by phone at 1-800-474-7493, and by mail using the enclosed pre–paid envelope.For more information, shareholders should contact Canopy Growth's strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory Group, at 1-877-452-7184 (1–416–304–0211 for collect calls outside North America) or by email at [email protected] FALLS, ON, Aug. 13, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy G
NASDAQ | TSX: ACB EDMONTON, AB, Aug. 12, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date. All of
SC 13D/A - IGC Pharma, Inc. (0001326205) (Subject)
SC 13G/A - WM TECHNOLOGY, INC. (0001779474) (Subject)
SC 13D/A - WM TECHNOLOGY, INC. (0001779474) (Subject)
Weedmaps (NASDAQ:MAPS), a prominent online cannabis marketplace, announced a partnership with NuggMD, the leading telemedicine platform for medical cannabis patients. This collaboration aims to streamline the medical cannabis education and application process for patients through a new pilot program. Initial Phase And Target States The program seeks to improve access to medical cannabis by connecting potential patients on Weedmaps with NuggMD’s telehealth platform, according to a press release. The initial phase is active in Florida, Oklahoma, Pennsylvania, West Virginia and Louisiana, five states served by NuggMD. Patient Education And Convenience “We’re seeing more and more po
Under the new license, Aurora may also cultivate an approved additional product, and plans to expand their offerings to the rapidly growing German patient base. Aurora will also receive a dedicated R&D license, allowing for the trial of up to seven additional novel cultivars at the company's local EU GMP facility in Leuna, Germany.
California's Glass House Reappoints Board Member As Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 for its 19th edition, gathering top CEOs, investors investors and leaders in the cannabis industry, let’s scroll through the latest leadership changes in the space. Get your tickets now before prices surge by following this link. Long Beach, California-based vertically-integrated cannabis company Glass House Brands Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX:GLASF) (OTCQX:GHBWF) announced last week the reappointment of Hector De La Torre to its board of directors. De La Torre previously served as an original member of the board until 2023. At the time, he s
GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United States, announced today that Darren Lampert, Chief Executive Officer and Co-Founder, will participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference on Thursday, September 12, 2024, at the Yale Club in Midtown Manhattan, New York City. The Company will host one-on-one investor meetings throughout the conference. For more information or to schedule a meeting, please contact your Lake Street representative at [email protected] or email [email protected]. About GrowGeneration
TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") is expanding its portfolio for its Lord Jones® brand with new innovations to bolster its lineup of premium cannabis products in the Canadian market. The additions include new cultivars for the Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, which are now available across Canada. Since the brand's launch in Canada in November 2023, Ice Water Hash Fusions Pre-Rolls have become the best-selling hash-infused pre-rolls in the country1. Curated with flower and terpene-rich ice water hash and fitted with a branded ceramic tip designed to cool the smoke, the
IGC Pharma, Inc. ("IGC" or the "Company") (NYSE:IGC) announces that during its Annual Meeting of Stockholders scheduled for and convened on August 23, 2023 (the "Annual Meeting"), all proposals as disclosed on the Definitive Proxy Statement on Schedule 14A filed with the SEC on July 8, 2024, were passed by the requisite vote of the stockholders. Only stockholders of record on the record date of June 28, 2024, were entitled to and requested to vote at the Annual Meeting. At the Annual Meeting, all of the following proposals were approved by the requisite vote of the stockholders: (i) the election of Mr. Richard Prins and Mr. Terry Lierman to the Company's board of directors to serve as Cla
Canaccord Genuity resumed coverage of SNDL Inc. with a rating of Speculative Buy
Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously
Oppenheimer downgraded GrowGeneration from Outperform to Perform
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Aug. 23, 2024 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that
IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO and GLIL YAM, Israel, Aug. 14, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended June 30, 2023, unless otherwise stated. Q2 2024 Financial Highlights 12% Revenue increase to $14.8M vs. $13.2M in Q2 2023 129% increase in IMC Germany sales vs. Q2 2023 to $3.5M. IMC Germany sales now make up 24% of the entire Company r
Focus on profitable revenue generation delivered 67% increase in gross profit year-over-year Record quarter for Canada Medical Cannabis with Net Revenue increasing 20% year-over-year and 6th consecutive quarter of growth Extended maturity of senior secured term loan to December 18, 2026 with an option to further extend to September 18, 2027 SMITHS FALLS, ON, Aug. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the first quarter ended June 30, 2024 ("Q1 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
DEFA14A - Canopy Growth Corp (0001737927) (Filer)
8-K - Canopy Growth Corp (0001737927) (Filer)